The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.2% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it none, with a mean price target of $96. It reported earnings in this window, a natural checkpoint for the thesis.
Donaldson Company, Inc.
DCI · the NYSE · USD · 15,000 employees
Donaldson Company, Inc.
PASS · Titan Ethical · score 70.0At the last full screen
2026-08-25
Screened 2026-08-25 · the tape above runs as of 15:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Donaldson Company, Inc. holds its Markdown at $93.26. The statistical read favours the buyers, held for 41 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 41 days |
| Price at the screen | $93.26 |
| Valuation | 25.14 trailing · 21.17 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 0.93 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 22.45% | Below 33% | Interest-bearing debt is just 22.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 28.30% | Below 49% | Money owed to the company is 28.3% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-08-25 screen. The gold marker is the market price at the same screen. The price runs 1.3% above the base estimate.
Third-party analyst targets: 5 covering, consensus Hold. The average target sits +3% from the screen price.
Reading the gap · Our model and the Street both land near today's price: fairly valued, with no strong edge either way.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-08-25 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsFilters That Keep Global Engines Running
Every time a truck crosses a continent or a factory keeps its air clean, Donaldson supplies the filtration that makes it possible. The business posts a solid 28% ROE and 12% profit margins while growing revenue at 6% a year, yet the shares trade at 20.6 times forward earnings, almost exactly our fair value.
That leaves little margin of safety at the current price near 90 dollars against our 91 dollar assessment. The ethical screen clears, and the replacement-parts model brings some stability, but unknown competitive protection and single-digit top-line growth do not mark it out as compelling.
Cyclical industrial demand remains the main risk, with any slowdown in heavy equipment or manufacturing quickly hitting volumes. Five analysts see a median target of 95 dollars, yet the thin cushion here offers no real opportunity. Analysis, not advice.
| Forward P/E | 21.2xexpensive even after accounting for its growth |
| Trailing P/E | 25.1xa premium valuation |
| EPS, trailing | 3.71 |
| EPS, forward | 4.41 |
| Revenue growth | +5.8%slow but positive growth |
| Profit margin | 11.5%thin but positive margins |
| Return on equity | 27.8%an exceptional return on shareholder capital |
| Dividend yield | 141.00% |
| Debt to equity | 0.36minimal debt: a conservative balance sheet |
| Current ratio | 2.35comfortably covers its short-term bills |
| Beta | 0.93steadier than the market |
| Short interest, float | 0.03% |
| 52-week range | 75.58 - 112.84 |
| Employees | 15,000 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeDCI trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it none, with a mean price target of $96. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it none, with a mean price target of $96. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it none, with a mean price target of $96. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it none, with a mean price target of $96.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 21%. Our forward projection puts the odds of a 10% gain over the next month near 15%. The street (5 analysts) rates it none, with a mean price target of $96.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $85.59 | -1.8% | · | $982 | -1.8% |
| 2 months | $88.65 | -5.2% | · | $948 | -5.2% |
| 3 months | $86.98 | -3.4% | · | $966 | -3.4% |
| 6 months | $92.82 | -9.5% | $0.30 | $909 | -9.1% |
| 1 year | $69.57 | +20.8% | $1.20 | $1,225 | +22.5% |
| 2 years | $71.55 | +17.5% | $2.28 | $1,206 | +20.6% |
| 3 years | $57.59 | +45.9% | $3.03 | $1,512 | +51.2% |
| 5 years | $57.55 | +46.0% | $4.86 | $1,545 | +54.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever DCI does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.